BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 19, 2003
View Archived Issues
Four related series of gamma-secretase inhibitors designed by Merck researchers
Read More
Kirin Brewery patent covers M-CSF inhibitors able to prevent bone metastasis and osteoporosis
Read More
New tyrosine kinase inhibitors, their preparation and use covered by Merck patent
Read More
Chugai researchers discover novel biguanide-based antidiabetic agents
Read More
Novel HDAC inhibitors idenified at AstraZeneca
Read More
Ximelagatran superior to warfarin in preventing VTE after total knee replacement
Read More
Clinical benefits of gene therapy with Ad-CD154 for CLL
Read More
Preliminary evaluation of NS-1209 in patients with status epilepticus
Read More
Potential use of bispecific antibody Bi20 in patients with B-cell lymphoma
Read More
Pixantrone shows antitumor efficacy in relapsed/refractory NHL
Read More
Active Biotech TTS development to focus on TTS CD3
Read More
AEterna focuses Neovastat program on NSCLC
Read More
APD-356 completes preclinical testing
Read More
Eligard approved in Australia
Read More
Clinical effect observed in phase I study of BCX-1777 in T-cell malignancies
Read More
Second phase I study of ETC-642 shows evidence of cholesterol mobilization
Read More
Enrollment completed in European rhATIII study
Read More
Interim analysis reported for Infergen/Actimmune in hepatitis C nonresponders
Read More
Enrollment under way in pivotal INSPIRE study of Actimmune for IPF
Read More
Riquent NDA submitted to FDA
Read More
New clinical study evaluates SEPA-enhanced testosterone
Read More
Phase II trials evaluate Vitaxin for prostate cancer and psoriasis
Read More
MBI-2401 is lead development candidate from Micrologix lipopeptide program
Read More
Vertex and OHSU enter drug discovery and development collaboration
Read More
Preclinical findings for SGN-40 summarized at ASH meeting
Read More
Oxycyte studied for cardiac surgery
Read More
Fuzeon 48-week data submitted to support full FDA approval
Read More